Dr. Tamrat Bekele, MD

Dr. Bekele practices at Geisinger Community Medical Center in Scranton, Pennsylvania, part of Risant Health.

Dr. Bekele's NPI, 1376545947, was assigned on August 12, 2005. Dr. Bekele holds Pennsylvania license MD065698L.

Dr. Bekele's primary practice is Geisinger Community Medical Center, at 1822 Mulberry Street, Scranton, PA 18510 in Lackawanna County. The practice phone is (570) 703-8000. Dr. Bekele also practices at Geisinger Community Medical Center, 1800 Mulberry St, Scranton, PA 18510.

Dr. Bekele's primary practice is Geisinger Community Medical Center in Scranton, Pennsylvania, part of Risant Health. Dr. Bekele is also affiliated with Regional Hospital of Scranton. Dmand AI also links Dr. Bekele to 4 more hospitals, 4 home health agencies, 4 hospices and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bekele practices, 15 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Bekele's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Bekele is licensed in Pennsylvania.

CMS data shows 1,823 Medicare services from Dr. Bekele across 14 procedure codes in 2024, for 481 Medicare patients. Medicare paid $155,636 for them. Every service was in an office.

CMS counts 481 Medicare patients who saw Dr. Bekele in 2024. The largest group is 65 to 74, with 191 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bekele's median patient age at 72, with 67% women.

In 2024, Dr. Bekele wrote 11,637 Medicare Part D claims for 673 patients. 88% of them were for generic drugs. CMS names the drug for 10,917 of them, across 148 drugs with 11 or more claims each, at $968,761 in total drug cost. In 2023, CMS named 11,143 claims across 156 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Bekele for performance year 2024, reported individually. Dr. Bekele accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Bekele, published from 2011 to 2012. 2011 was the busiest year, with 2. The most frequent topics are Ethiopia. Dr. Bekele's most frequent co-authors are Ranjodh S. Dhami, MD and Wint Su Wai, MD.

CMS Open Payments shows 765 general payments to Dr. Bekele from 43 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $1,793.